Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 2/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.40 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19920853 | 0.89 | ESR2 (0.50) | ESR2NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL10341375 | 0.89 | ESR2 (0.55) | ESR2PDK2NPC1RAB9AHPGD | |
| SCHEMBL7776584 | 0.87 | ESR2 (0.53) | ESR2PDK2NPC1RAB9AHPGD | |
| SCHEMBL141537 | 0.87 | PGR (0.49) | ESR2PDK2NPC1RAB9AHPGD | |
| SCHEMBL31026066 | 0.87 | PGR (0.49) | ESR2PDK2NPC1RAB9AHPGD | |
| SCHEMBL3026086 | 0.83 | PGR (0.50) | PDK2RAB9ACNR2PGRCNR1 | |
| SCHEMBL3689436 | 0.79 | PGR (0.44) | ESR2PDK2PGRMAPTPARP10 | |
| SCHEMBL9876129 | 0.77 | CNR2 (0.51) | ESR2PDK2NPC1RAB9AHPGD | |
| SCHEMBL5013854 | 0.77 | ESR2 (0.63) | ESR2NPC1RAB9ASMN1; SMN2MAPT | |
| SCHEMBL16192737 | 0.77 | ESR2 (0.63) | ESR2NPC1RAB9ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10436790-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | WATERS TECHNOLOGIES CORPORATION (US) | 2019-10-08 | — | — | US | disclosed |
| US-20140350263-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2014-11-27 | — | — | US | disclosed |
| US-6844963-B2 | Double-resonance-absorption microscope | OLYMPUS OPTICAL CO., LTD. (JP) | 2005-01-18 | — | — | US | disclosed |
| US-20010045529-A1 | Double-resonance-absorption microscope | OLYMPUS CORPORATION (JP) | 2001-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350263-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | FUT5, FUT6, CSGALNACT1 | ESR2 4457/4885PDK2 3974/4885NPC1 2683/4885 |
| US-10436790-B2 | Rapid fluorescence tagging of glycans and other biomolecules with enhanced MS signals | FUT5, FUT6, CSGALNACT1 | ESR2 4194/4885PDK2 4028/4885NPC1 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.